Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.
Industries BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeuticsHeadquarters Regions San Francisco Bay Area, Silicon Valley, West Coast Founded Date 2012 Founders AmirAli Talasaz, Helmy Eltoukhy Operating Status Active Last Funding Type Post-IPO Equity Legal Name Guardant Health, Inc.
Stock Symbol NASDAQ:GH Company Type For Profit
Number of Exits
Contact Email press@guardanthealth.com Phone Number 650-290-7575
Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and rare-cell
diagnostics, and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad.